Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents

Clinical Trial ID NCT01443104

Rank	Title	Journal	Year	PubWeight™‹?›
1	Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial.	Lancet	2014	1.74
2	A Review of the Key Clinical Trials of 2014.	Cardiol Ther	2015	1.38
3	Impact of Diabetic Status on Outcomes After Revascularization With Drug-Eluting Stents in Relation to Coronary Artery Disease Complexity: Patient-Level Pooled Analysis of 6081 Patients.	Circ Cardiovasc Interv	2016	0.77
4	Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: rationale and design of the BIOSCIENCE trial.	Am Heart J	2014	0.77
5	Clinical outcomes according to diabetic status in patients treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: prespecified subgroup analysis of the BIOSCIENCE trial.	Circ Cardiovasc Interv	2015	0.76
6	Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE Trial.	J Am Heart Assoc	2016	0.75
7	Anatomic characteristics and clinical implications of angiographic coronary thrombus: insights from a patient-level pooled analysis of SYNTAX, RESOLUTE, and LEADERS Trials.	Circ Cardiovasc Interv	2015	0.75